Biocoat Releases Three New Hydrophilic Coatings

Biocoat, Inc., maker of lubricious HYDAK® hydrophilic coatings introduced three new hydrophilic coatings for medical devices to its classic lineup.

Horsham, PA (PRWEB)  - Biocoat, Inc., maker of lubricious HYDAK® hydrophilic coatings introduced three new hydrophilic coatings for medical devices to its classic lineup. "HydroSleek2," the new successor to the original HydroSleek lubricious coating, with improved processing and biocompatibility. "The HydroSleek Kit" is another variation on the HydroSleek coating, which allows the product to be stored and transported under a wider array of conditions. Third, the "Hydak® T-040 Kit" is a remake of another classic, "Hydak® L-110," also allowing for wider availability to Asian and European markets.

All of these coatings are based on high molecular weight Hyaluronic Acid (HA). This technology has applications among a range of fields including ophthalmology, urology, cardiology, endoscopy, and neurovascular. HydroSleek coatings have overcome the trade off between lubricity and durability seen in cross-linked coatings. Additionally, HydroSleek involves a heat-cure process so both ID and OD may be coated without the concerns surrounding UV curing.

These new products will act as Biocoat's front line solution to medical device firms seeking to reduce surface friction for their devices. Each of these new products possesses the same beneficial characteristics of the family of HYDAK® coatings, plus advancements device manufacturers have requested.

For further information on these coatings, visit http://www.biocoat.com. Or, contact Dr. Josh Simon, Senior Product Manager at 215-734-0888, Ext. 115.

Biocoat, Inc. is research and development company with core competencies focusing on coatings development and licensing. The company enables its clients to tailor its HYDAK® and other coating technologies to specific surfaces, and acts as a support network for development and manufacturing throughout the project/product life cycle.

SOURCE: PRWeb
View original release here: http://www.prweb.com/releases/2012/5/prweb9482925.htm